Direct Homo- and Hetero-Interactions of MeCP2 and MBD2

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Becker, Annette ^a   Allmann, Lena ^a   Hofstätter, Maria ^b   Casà, Valentina ^a   Weber, Patrick ^a   Lehmkuhl, Anne ^a   Herce, Henry D ^a   Cardoso, M Cristina ^a  

^a DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYTOSINE; METHYL CPG BINDING PROTEIN 2;

ARTICLE; CHROMATIN; CHROMATIN STRUCTURE; EPIGENETICS; GENE DELETION; GENE EXPRESSION; HETEROCHROMATIN; HUMAN; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; MAMMAL CELL; METHYLATION; MOLECULAR MECHANICS; PROTEIN PROTEIN INTERACTION; TWO HYBRID SYSTEM;

ANIMALS; CELL LINE; CHROMATIN; DNA-BINDING PROTEINS; GENE EXPRESSION; HUMANS; METHYL-CPG-BINDING PROTEIN 2; MICE; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING;

MAMMALIA;

EID: 84872371295     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053730     Document Type: Article

References (36)

1. Rottach A, Leonhardt H, Spada F, (2009) DNA methylation-mediated epigenetic control. J Cell Biochem 108: 43-51.
2. Brero A, Leonhardt H, Cardoso MC, (2006) Replication and translation of epigenetic information. Curr Top Microbiol Immunol 301: 21-44.
3. Nan X, Meehan RR, Bird A, (1993) Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucleic Acids Res 21: 4886-4892.
4. Hendrich B, Bird A, (1998) Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol 18: 6538-6547.
5. Saito M, Ishikawa F, (2002) The mCpG-binding domain of human MBD3 does not bind to mCpG but interacts with NuRD/Mi2 components HDAC1 and MTA2. J Biol Chem 277: 35434-35439.
6. Wade PA, Gegonne A, Jones PL, Ballestar E, Aubry F, et al. (1999) Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation. Nat Genet 23: 62-66.
7. Brero A, Easwaran HP, Nowak D, Grunewald I, Cremer T, et al. (2005) Methyl CpG-binding proteins induce large-scale chromatin reorganization during terminal differentiation. J Cell Biol 169: 733-743.
8. Fuks F, Hurd PJ, Wolf D, Nan X, Bird AP, et al. (2003) The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J Biol Chem 278: 4035-4040.
9. Harikrishnan KN, Chow MZ, Baker EK, Pal S, Bassal S, et al. (2005) Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing. Nat Genet 37: 254-264.
10. Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, et al. (1998) Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 19: 187-191.
11. Kokura K, Kaul SC, Wadhwa R, Nomura T, Khan MM, et al. (2001) The Ski protein family is required for MeCP2-mediated transcriptional repression. J Biol Chem 276: 34115-34121.
12. Lunyak VV, Burgess R, Prefontaine GG, Nelson C, Sze SH, et al. (2002) Corepressor-dependent silencing of chromosomal regions encoding neuronal genes. Science 298: 1747-1752.
13. Nan X, Campoy FJ, Bird A, (1997) MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88: 471-481.
14. Nan X, Hou J, Maclean A, Nasir J, Lafuente MJ, et al. (2007) Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation. Proc Natl Acad Sci U S A 104: 2709-2714.
15. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, et al. (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393: 386-389.
16. Georgel PT, Horowitz-Scherer RA, Adkins N, Woodcock CL, Wade PA, et al. (2003) Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation. J Biol Chem 278: 32181-32188.
17. Skene PJ, Illingworth RS, Webb S, Kerr AR, James KD, et al. (2010) Neuronal MeCP2 Is Expressed at Near Histone-Octamer Levels and Globally Alters the Chromatin State. Mol Cell 37: 457-468.
18. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, et al. (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23: 185-188.
19. Amir RE, Zoghbi HY, (2000) Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations. Am J Med Genet 97: 147-152.
20. Agarwal N, Becker A, Jost KL, Haase S, Thakur BK, et al. (2011) MeCP2 Rett mutations affect large scale chromatin organization. Hum Mol Genet 20: 4187-4195.
21. Casas-Delucchi CS, Becker A, Bolius JJ, Cardoso MC (2012) Targeted manipulation of heterochromatin rescues MeCP2 Rett mutants and re-establishes higher order chromatin organization. Nucleic Acids Res doi: 10.1093/nar/gks784.
22. Nikitina T, Ghosh RP, Horowitz-Scherer RA, Hansen JC, Grigoryev SA, et al. (2007) MeCP2-chromatin interactions include the formation of chromatosome-like structures and are altered in mutations causing Rett syndrome. J Biol Chem 282: 28237-28245.
23. Chandler SP, Guschin D, Landsberger N, Wolffe AP, (1999) The methyl-CpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA. Biochemistry 38: 7008-7018.
24. Ghosh RP, Nikitina T, Horowitz-Scherer RA, Gierasch LM, Uversky VN, et al. (2010) Unique physical properties and interactions of the domains of methylated DNA binding protein 2. Biochemistry 49: 4395-4410.
25. Ghosh RP, Horowitz-Scherer RA, Nikitina T, Shlyakhtenko LS, Woodcock CL, (2010) MeCP2 binds cooperatively to its substrate and competes with histone H1 for chromatin binding sites. Mol Cell Biol 30: 4656-4670.
26. Adams VH, McBryant SJ, Wade PA, Woodcock CL, Hansen JC, (2007) Intrinsic disorder and autonomous domain function in the multifunctional nuclear protein, MeCP2. J Biol Chem 282: 15057-15064.
27. Klose RJ, Bird AP, (2004) MeCP2 behaves as an elongated monomer that does not stably associate with the Sin3a chromatin remodeling complex. J Biol Chem 279: 46490-46496.
28. Rothbauer U, Zolghadr K, Muyldermans S, Schepers A, Cardoso MC, et al. (2008) A versatile nanotrap for biochemical and functional studies with fluorescent fusion proteins. Mol Cell Proteomics 7: 282-289.
29. Jost KL, Rottach A, Milden M, Bertulat B, Becker A, et al. (2011) Generation and characterization of rat and mouse monoclonal antibodies specific for MeCP2 and their use in X-inactivation studies. PLoS One 6: e26499.
30. Agarwal N, Hardt T, Brero A, Nowak D, Rothbauer U, et al. (2007) MeCP2 interacts with HP1 and modulates its heterochromatin association during myogenic differentiation. Nucleic Acids Res 35: 5402-5408.
31. Yaffe D, Saxel O, (1977) Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270: 725-727.
32. Pichler G, Leonhardt H, Rothbauer U, (2012) Fluorescent protein specific nanotraps to study protein-protein interactions and histone-tail Peptide binding. Methods Mol Biol 911: 475-483.
33. Mortusewicz O, Rothbauer U, Cardoso MC, Leonhardt H, (2006) Differential recruitment of DNA Ligase I and III to DNA repair sites. Nucleic Acids Res 34: 3523-3532.
34. Rottach A, Kremmer E, Nowak D, Leonhardt H, Cardoso MC, (2008) Generation and characterization of a rat monoclonal antibody specific for multiple red fluorescent proteins. Hybridoma (Larchmt) 27: 337-343.
35. Dantzer F, Giraud-Panis MJ, Jaco I, Ame JC, Schultz I, et al. (2004) Functional interaction between poly(ADP-Ribose) polymerase 2 (PARP-2) and TRF2: PARP activity negatively regulates TRF2. Mol Cell Biol 24: 1595-1607.
36. Zolghadr K, Mortusewicz O, Rothbauer U, Kleinhans R, Goehler H, et al. (2008) A fluorescent two-hybrid assay for direct visualization of protein interactions in living cells. Mol Cell Proteomics 7: 2279-2287.